Recurrent Intrahepatic Cholangiocarcinoma
3 clinical trials · Condition
◉ Watch Recurrent Intrahepatic Cholangiocarcinoma
| Record | Firm | Date |
|---|---|---|
| Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) (NCT05564403) | National Cancer Institute (NCI) | 2024-02-09 |
| Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer (NCT04941287) | National Cancer Institute (NCI) | 2021-12-15 |
| Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (NCT03257761) | University of Southern California | 2018-02-07 |
Track Recurrent Intrahepatic Cholangiocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.